CLINICA CHIMICA ACTA

Clinica Chimica Acta出版了临床化学和实验室医学领域的原始研究通讯，定义为化学、生物化学、免疫化学、血液学的生化方面、毒理学和分子生物学在体液、细胞或组织中人类疾病研究中的应用，其目标是该杂志将出版新的信息，以更好地了解人类疾病的生物学机制、预防、诊断和患者管理。也欢迎有关应用临床特征的报告。有关正常代谢过程或正常细胞或体液成分的论文，如动物实验或临床研究报告，在其中被认为与人类疾病有明确和直接的关系。还将考虑开发和评估适用于临床化学和实验室医学的新型分析方法，包括护理点测试，以及关于实验室管理和信息学的主题。除了最初的研究通讯外，该杂志还出版：（1）提供结论性结果或文件方法进展的有限范围的简短通讯报告；（2）致编辑的信，对发表在《临床化学学报》上的论文发表评论-这些应该少于400个字，可能包括1个插图。R 1表；（3）邀请对医学生物化学和实验室医学的最新中心发展进行评论；（4）涉及有趣或新颖临床实验室数据的病例报告；（5）科学学会通讯；（6）会议公告。提交给Clinica Chimica Acta的打字稿以前不应出版，也不应考虑在其他地方出版。必须确认所有指定作者同意提交。涉及人或动物的调查必须注意相关的伦理批准。如果作者对提议论文的范围、格式或内容有任何疑问，请咨询编辑委员会的任何成员。

Clinica Chimica Acta publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids, cells or tissues The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are considered in they are clearly and directly relevant to human disease. Development and evaluation of novel analytical methologies where applicable to clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. In addition to original Research Communications the journal publishes: (1) Short Communications-concise reports of limited scope which offer conclusive results or document methodological advances; (2) Letters to the Editor, commenting on papers published in Clinica Chimica Acta - these should be less than 400 words and may include 1 illustration or 1 table; (3) Invited Critical Reviews of recent central developments in medical biochemistry and laboratory medicine; (4) case reports involving interesting or novel clinical laboratory data; (5) Newsletters of Scientific Societies; (6) Meeting announcements. Typescripts submitted to Clinica Chimica Acta should not have been published previously and should not be under consideration for publication elsewhere. The agreement of all named authors to the submission must be affirmed. Relevant ethical approval must be noted for investigations involving human or animal subjects. Authors are invited to consult any member of the Editorial Board, if in doubt about any aspect of scope, format or content of a proposed paper.